[HTML][HTML] Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.
VA Zampeli, U Lippert, G Nikolakis… - Journal of …, 2015 - ncbi.nlm.nih.gov
VA Zampeli, U Lippert, G Nikolakis, E Makrantonaki, TG Tzellos, U Krause, CC Zouboulis
Journal of Dermatological Case Reports, 2015•ncbi.nlm.nih.govBackground Pyoderma gangraenosum is an immune-mediated, inflammatory, neutrophilic
dermatosis of unknown etiology, which represents one of the extraintestinal manifestations
of inflammatory bowel disease. It is a rare disease that occurs in less than 1% of patients
with inflammatory bowel disease and with the same ratio in patients with Crohn's disease
and ulcerative colitis.
dermatosis of unknown etiology, which represents one of the extraintestinal manifestations
of inflammatory bowel disease. It is a rare disease that occurs in less than 1% of patients
with inflammatory bowel disease and with the same ratio in patients with Crohn's disease
and ulcerative colitis.
Abstract
Background
Pyoderma gangraenosum is an immune-mediated, inflammatory, neutrophilic dermatosis of unknown etiology, which represents one of the extraintestinal manifestations of inflammatory bowel disease. It is a rare disease that occurs in less than 1% of patients with inflammatory bowel disease and with the same ratio in patients with Crohn's disease and ulcerative colitis.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果